IDSA: Antibiotics for Seven Days Feasible for Patients Hospitalized With Bloodstream Infections
By Lori Solomon HealthDay Reporter
MONDAY, Oct. 21, 2024 -- Treating hospitalized patients with bloodstream infections with antibiotics for seven days is noninferior to treating for 14 days, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.
Nick Daneman, M.D., and Rob Fowler, M.D., from the University of Toronto, and colleagues randomly assigned 3,608 hospitalized patients (ward and intensive care unit [ICU]) with bloodstream infections to receive seven- or 14-day (1,814 and 1,794 patients, respectively) antibiotic treatment.
The researchers reported that most infections were community-onset (75.4 percent), followed by hospital-acquired (13.4 percent) and ICU-acquired (11.2 percent). The urinary tract (42.2 percent), abdomen (18.8 percent), lung (13.0 percent), vascular catheters (6.3 percent), and skin or soft tissue (5.2 percent) were the most common bacteremia sources. Ninety-day mortality occurred in 14.5 percent of patients receiving seven-day and in 16.1 percent of patients receiving 14-day treatment, demonstrating noninferiority of shorter duration treatment. Noninferiority was confirmed in a per-protocol analysis (−2.0 percent; 95 percent confidence interval, −4.5 to 0.6). Findings were similar across secondary clinical outcomes and prespecified patient, pathogen, and syndrome subgroups.
"Finding strong evidence that supports shorter antibiotic treatment durations is a top priority to advance antimicrobial stewardship as drug-resistant bacteria are increasingly becoming a public health threat," Daneman said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
FDA Warns of Possible Bacteria Contamination of Tattoo Inks
FRIDAY, May 9, 2025 -- Two tattoo inks have tested positive for harmful bacteria and the use of them could lead to serious infections, according to an alert from the U.S. Food and...
Quality Improvement Program Aids Antibiotic Duration for Common Infections in Children
WEDNESDAY, May 7, 2025 -- A quality improvement program can improve recommended antibiotic duration in children for both acute otitis media (AOM) and community-acquired pneumonia...
Sustainable Development Strategies Can Reduce Global Antimicrobial Resistance
WEDNESDAY, May 7, 2025 -- Sustainable development strategies are important for helping low- and middle-income countries to address the dual challenges of climate change and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.